The FDA has approved the use of Deerfield Imaging’s SYMBIS stereotactic brain biopsy system. The system allows for robotic biopsies of the brain to be performed simultaneously with an MRI. The goal of the SYMBIS system is to improve the visualization of targeted areas, and procedure time for biopsies. As the system allows for a visual representation of the target, it can also improve tissue sampling and reduce the need for repeat biopsies.
The FDA approval is a huge success for the company, and they now plan to use the SYMBIS as a stepping stone for future neurosurgical tools as well as other medical devices.